Association Between Colitis and Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Event Reporting System (FAERS)

被引：0
|
作者：
Tunio, Nahel A. [1 ]
Cooper, Gregory S. [1 ]
机构：
[1] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000590048.19557.62
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
129
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 50 条
  • [31] Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
    Wen, Ming-Tao
    Li, Jia-Cheng
    Lu, Bo-Wen
    Shao, Hua-Rong
    Ling, Pei-Xue
    Liu, Fei
    Li, Gang
    Luo, Di
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [32] Association between GvHD and nivolumab in the FDA adverse event reporting system
    Oshima, Y.
    Tanimoto, T.
    Yuji, K.
    Tojo, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (10) : 1463 - 1464
  • [33] Association between GvHD and nivolumab in the FDA adverse event reporting system
    Y Oshima
    T Tanimoto
    K Yuji
    A Tojo
    Bone Marrow Transplantation, 2017, 52 : 1463 - 1464
  • [34] Association of additional malignancies not previously recognized in the FDA Full Prescribing Information for ustekinumab: An analysis of the FDA Adverse Event Reporting System (FAERS)
    Florek, Aleksandra G.
    Nardone, Beatrice
    Thareja, Shalini
    Tran, Gary
    Giles, Francis J.
    West, Dennis P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB220 - AB220
  • [35] Association of sacubitril/valsartan with hypoacusis unveiled through disproportionality analysis in US FDA adverse event reporting system (FAERS)
    Chiranjeevi, Pudi
    Saraswathy, G. R.
    Viswam, Subeesh Kulangara
    Swaroop, Ann Mary
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 131 - 131
  • [36] Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
    Zhou, Jianxing
    Wei, Zipeng
    Xu, Baohua
    Liu, Maobai
    Xu, Ruichao
    Wu, Xuemei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
    Morris, Robert
    Ali, Rahinatu
    Cheng, Feng
    CURRENT DRUG TARGETS, 2024, 25 (07) : 454 - 464
  • [38] Rheumatological Immune-Related Adverse Events of Immune Checkpoint Inhibitors Based on the FDA Adverse Event Reporting System
    Rodriguez-Pla, Alicia
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 901 - 903
  • [39] WEBER EFFECT: AN EXTENDED ANALYSIS FOR TEN YEARS OF REPORTING TRENDS IN FDA ADVERSE EVENT REPORTING SYSTEM (FAERS)
    Beulah, E.
    Reddy, N.
    Subeesh, V
    Maheswari, E.
    Pudi, C.
    VALUE IN HEALTH, 2018, 21 : S369 - S369
  • [40] Atezolizumab and severe cutaneous adverse reactions: a disproportionality analysis using FDA Adverse Event Reporting System (FAERS)
    Pecere, Alessandro
    Bisinella, Giulia Carlotta
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 35 - 35
12345